Clinical trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
NCT02510547 is registered in ClinicalTrials.gov with North Texas Veterans Healthcare System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
- Lead sponsor
- North Texas Veterans Healthcare System
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- August 31, 2017
- Enrollment
- 246 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.